Diskussionsleitung: B. Kirstein (Lübeck), A. Pott (Lingen)
| (P2188) | Age-differences of patients treated with wearable cardioverter defibrillator: data from a multicenter Registry | |
| I. El-Battrawy, B. Kovacs, T. Dreher, C. Blockhaus, N. Klein, D.-I. Shin, S. L. Rosenkaimer, T. Beiert, M. Abumayyaleh, A. Saguner, J. W. Erath-Honold, F. Duru, A. Mügge, A. Aweimer, I. Akin (Bochum, Mannheim, Krefeld, Leipzig, Bonn, Frankfurt am Main; Zürich, CH) | ||
| (P2189) | The use of Wearable cardioverter defibrillator among patients suffering from myocarditis: data from a multicenter Registry | |
| I. El-Battrawy, K. Koepsel, B. Kovacs, T. Dreher, C. Blockhaus, M. Gotzmann, N. Klein, D.-I. Shin, M. Abumayyaleh, H. Lapp, A. Saguner, J. W. Erath-Honold, F. Duru, A. Mügge, A. Aweimer, I. Akin, T. Beiert (Bochum, Zürich, Mannheim, Krefeld, Leipzig, Bonn, Frankfurt am Main) | ||
| (P2190) | NAG provides advanced prognostic capabilities in patients suffering from DCM compared to coronary artery disease in a cohort of ICD patients, opposite to urinary NT-proBNP | |
| R. Allgaier, C. Strack, S. Wallner, U. Hubauer, E. Ücer, P. Lehn, A. Keyser, A. Luchner, L. S. Maier, C. G. Jungbauer (Regensburg) | ||
| (P2191) | Urinary and plasma N-terminal pro-brain natriuretic peptide predict impairment of longitudinal left ventricular function in a prospective cohort of ICD patients | |
| J. Zeller, S. Sag, R. Allgaier, C. Meindl, A. Schober, A. Schober, U. Hubauer, A. Luchner, L. S. Maier, C. G. Jungbauer (Regensburg) | ||
| (P2192) | Genetic factors in the development of tachycardia-induced cardiomyopathy | |
| N. Dybkova, C. Brand, N. Hartmann, S. Rebs, P. Tirilomis, J. Beier, A. Zibat, D. Vollmann, G. Hasenfuß, B. Wollnik, S. T. Sossalla, K. Streckfuß-Bömeke (Göttingen, Regensburg, Würzburg) |